On September 6, 2024, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers (DoP) unveiled the Uniform Code for Marketing Practices in Medical Devices, 2024 (UCMPMD 2024) with a view towards providing a set of guidelines that would mitigate unethical practices, and ensure transparency, integrity, and accountability in the marketing of medical devices across India. In this regard, UCMPMD 2024 is an addition to the Uniform Code for Pharmaceuticals Marketing Practice, 2024 (UCPMP 2024). While the foundation of UCMPMD 2024 and UCPMP 2024 have similarities, this new code for medical devices stands out with some subtle distinctions. The CEO of the company is responsible for the adherence of the code. In such pursuit, he/she is obligated to submit the self-declaration form (Annexure to UCMPMD 2024) regarding the compliance of the code within two months after the end of every financial year (FY) to the association, or directly on the UCPMP portal of the DoP. The UCMPMD 2024 mandates the continuous disclosure of expenses related to Evaluation samples, CME/CPD/ training or any other events. These disclosures must be uploaded within two months after the end of each FY on the UCMPMD portal of FICCI. The disclosure format of these submissions is placed at the end of the code and on FICCI UCMPMD Website as well. View More